Seeking Novel Druggable Targets and Drug Candidates in Obstetrics and Gynaecology

A pharmaceutical company focused on women’s health is seeking novel druggable targets and drug candidates in the area of obstetrics and gynaecology for in-licence or early collaborative opportunities. The team is interested in new compounds and targets that will provide therapeutic benefit in the area of women’s health, such as: infertility, polycystic ovary syndrome, diminished ovarian reserve, primary ovarian insufficiency, endometriosis, adenomyosis, uterine fibroid, menopause, senium, etc. 

Approaches of Interest:

• All mechanisms of action relating to obstetrics and gynaecology are of interest with examples being anti-fibrotic effect, ovulation failure, hormone replacement and osteoporosis
• Open to different modalities, with small molecules and peptides being of highest interest
• Anti-fibrotic drugs that can be applied to both gynaecological and non-gynaecological conditions 
• Research relating to novel contraceptives
• Novel screening methods to identify novel targets are also relevant

Developmental Stages of Interest:

• Opportunities at basic research phase to phase III are within scope
• There is a preference for research with proof of concept

Submission Information

Submission of one page, 200-300 word briefs are encouraged, along with any optional supplementary information e.g. relevant publications. In submitting to this campaign, you confirm that your submission contains only non-confidential information. 

Opportunity for Collaboration

Our client is open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case-by-case basis. Example outcomes include licensing assets, project/PhD funding, and research collaborations.